278 related articles for article (PubMed ID: 33947961)
1. Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR-ERBB2 pathway.
Bajpai D; Mehdizadeh S; Uchiyama A; Inoue Y; Sawaya A; Overmiller A; Brooks SR; Hasneen K; Kellett M; Palazzo E; Motegi SI; Yuspa SH; Cataisson C; Morasso MI
Oncogene; 2021 May; 40(21):3680-3694. PubMed ID: 33947961
[TBL] [Abstract][Full Text] [Related]
2. The homeoprotein DLX3 and tumor suppressor p53 co-regulate cell cycle progression and squamous tumor growth.
Palazzo E; Kellett M; Cataisson C; Gormley A; Bible PW; Pietroni V; Radoja N; Hwang J; Blumenberg M; Yuspa SH; Morasso MI
Oncogene; 2016 Jun; 35(24):3114-24. PubMed ID: 26522723
[TBL] [Abstract][Full Text] [Related]
3. A novel DLX3-PKC integrated signaling network drives keratinocyte differentiation.
Palazzo E; Kellett MD; Cataisson C; Bible PW; Bhattacharya S; Sun HW; Gormley AC; Yuspa SH; Morasso MI
Cell Death Differ; 2017 Apr; 24(4):717-730. PubMed ID: 28186503
[TBL] [Abstract][Full Text] [Related]
4. Do DLX3 and CD271 Protect Human Keratinocytes from Squamous Tumor Development?
Palazzo E; Marconi A; Pincelli C; Morasso MI
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31331058
[TBL] [Abstract][Full Text] [Related]
5. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion.
Reiners JJ; Singh KP
Carcinogenesis; 1997 Mar; 18(3):593-7. PubMed ID: 9067561
[TBL] [Abstract][Full Text] [Related]
7. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D
Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297
[TBL] [Abstract][Full Text] [Related]
8. Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-alpha-induced epidermal growth factor receptor activation but not p53 inactivation.
Shibata MA; Ward JM; Green JE; Merlino G
Mol Carcinog; 1997 Mar; 18(3):160-70. PubMed ID: 9115586
[TBL] [Abstract][Full Text] [Related]
9. MET signaling in keratinocytes activates EGFR and initiates squamous carcinogenesis.
Cataisson C; Michalowski AM; Shibuya K; Ryscavage A; Klosterman M; Wright L; Dubois W; Liu F; Zhuang A; Rodrigues KB; Hoover S; Dwyer J; Simpson MR; Merlino G; Yuspa SH
Sci Signal; 2016 Jun; 9(433):ra62. PubMed ID: 27330189
[TBL] [Abstract][Full Text] [Related]
10. CYLD inhibits tumorigenesis and metastasis by blocking JNK/AP1 signaling at multiple levels.
Miliani de Marval P; Lutfeali S; Jin JY; Leshin B; Selim MA; Zhang JY
Cancer Prev Res (Phila); 2011 Jun; 4(6):851-9. PubMed ID: 21478324
[TBL] [Abstract][Full Text] [Related]
11. Cocarcinogenic effect of capsaicin involves activation of EGFR signaling but not TRPV1.
Hwang MK; Bode AM; Byun S; Song NR; Lee HJ; Lee KW; Dong Z
Cancer Res; 2010 Sep; 70(17):6859-69. PubMed ID: 20660715
[TBL] [Abstract][Full Text] [Related]
12. ERBB2 Is Essential for the Growth of Chemically Induced Skin Tumors in Mice.
Dahlhoff M; Muzumdar S; Schäfer M; Schneider MR
J Invest Dermatol; 2017 Apr; 137(4):921-930. PubMed ID: 27931797
[TBL] [Abstract][Full Text] [Related]
13. IL-12 deficiency suppresses 12-O-tetradecanoylphorbol-13-acetate-induced skin tumor development in 7,12-dimethylbenz(a)anthracene-initiated mouse skin through inhibition of inflammation.
Sharma SD; Meeran SM; Katiyar N; Tisdale GB; Yusuf N; Xu H; Elmets CA; Katiyar SK
Carcinogenesis; 2009 Nov; 30(11):1970-7. PubMed ID: 19759192
[TBL] [Abstract][Full Text] [Related]
14. C3 Drives Inflammatory Skin Carcinogenesis Independently of C5.
Jackson WD; Gulino A; Fossati-Jimack L; Castro Seoane R; Tian K; Best K; Köhl J; Belmonte B; Strid J; Botto M
J Invest Dermatol; 2021 Feb; 141(2):404-414.e6. PubMed ID: 32682912
[TBL] [Abstract][Full Text] [Related]
15. XB130 deficiency enhances carcinogen-induced skin tumorigenesis.
Cho HR; Wang Y; Bai X; Xiang YY; Lu C; Post A; Al Habeeb A; Liu M
Carcinogenesis; 2019 Nov; 40(11):1363-1375. PubMed ID: 30820526
[TBL] [Abstract][Full Text] [Related]
16. β-Elemene inhibits 7,12-dimethylbenz(a)anthracene/12-O-tetradecanoylphorbol-13-acetate-induced skin tumorigenesis through suppression of NF-κB-associated signaling events in the mouse skin model.
Hu X; Wang L; Zhang L; Zhang T
J Biochem Mol Toxicol; 2020 Oct; 34(10):e22550. PubMed ID: 32662567
[TBL] [Abstract][Full Text] [Related]
17. Slit2 promotes tumor growth and invasion in chemically induced skin carcinogenesis.
Qi C; Lan H; Ye J; Li W; Wei P; Yang Y; Guo S; Lan T; Li J; Zhang Q; He X; Wang L
Lab Invest; 2014 Jul; 94(7):766-76. PubMed ID: 24840330
[TBL] [Abstract][Full Text] [Related]
18. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis.
Honeycutt KA; Chen Z; Koster MI; Miers M; Nuchtern J; Hicks J; Roop DR; Shohet JM
Oncogene; 2006 Jul; 25(29):4027-32. PubMed ID: 16518415
[TBL] [Abstract][Full Text] [Related]
19. TRP63/TP63 loss accelerates skin tumorigenesis through activation of Wnt/β-catenin signaling.
Lakshmanachetty S; Balaiya V; Johnson LK; Koster MI
J Dermatol Sci; 2018 Sep; 91(3):325-328. PubMed ID: 29885760
[No Abstract] [Full Text] [Related]
20. Non-melanoma skin cancer in mouse and man.
Schwarz M; Münzel PA; Braeuning A
Arch Toxicol; 2013 May; 87(5):783-98. PubMed ID: 23266722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
